InvestorsHub Logo

ombowstring

05/21/20 10:48 AM

#79225 RE: BGRDPL #79223

Credibilty. The FDA has got to take these people seriously.

drkazmd65

05/21/20 10:51 AM

#79227 RE: BGRDPL #79223

Good to see - can't hurt - might help here.

Amatuer17

05/21/20 10:57 AM

#79228 RE: BGRDPL #79223

Good find
The hospital is trying to push their contribution but mentions Cytodyn only once.

Any publicity is good

mercurio

05/21/20 11:16 AM

#79231 RE: BGRDPL #79223

Nice find and positive on the drug but Dr. Seethamraju is taking a lot of the credit for himself and some of the claims related to the hospital's involvement are misleading. Specifically, I am referring to:

Based on the positive results with those patients, the FDA approved Dr. Seethamraju’s application for a phase 2 trial of leronlimab. That trial began enrolling both inpatients and outpatients with mild-to-moderate COVID-19 on April 2. A total of 75 will participate.



The above neglects to mention CytoDyn or Dr. Patterson. Seems to me that Dr. Seethamraju is trying to take more credit than he is due.

Venture_Cap

05/21/20 12:34 PM

#79246 RE: BGRDPL #79223

Old news to us but still new news to the medical community since the media refuses to cover it.

It’s a shame it’s getting shaded like it is, people are dying unnecessarily.